PEAK Performance Compounding (PEAK-PCI) has invested in the addition of two advanced small twin-screw extruders, measuring 22mm and 32mm.
PEAK - PCI
These extruders represent technological advancements by including strand cut, underwater, and waterless pelletising capabilities. They offer complete pre- and post-drying functions, downstream feeding, and intricate pre- and post-blending and mixing. This equipment allows PEAK-PCI to provide small-lot compound batches, reducing excess waste and costs associated with larger extruders.
Todd Marchand, president of PEAK-PCI, said: “Product development is one of the most important facets of the manufacturing process. The integration of these cutting-edge twin-screw extruders affirms our company-wide dedication to no minimum order quantity. We are excited to forge partnerships in the development of next-generation products and technology, facilitating our customers’ journey from initial concept to full-scale production.”
These extruders are particularly beneficial for PEAK-PCI’s clients who encounter challenges with small-lot testing, sampling, and pre-production requirements. By offering full-range scalability, PEAK-PCI effectively supports the development, testing, and approval cycles, which are particularly critical in the medical device technology sector.
PEAK Performance Compounding is actively engaged in numerous R&D initiatives aimed at meeting the demands of an ever-evolving market. With a keen focus on the medical and industrial segments, PEAK has notably expanded its role in new medical device technologies, aiding clients through complex development processes.
The trends in medical and industrial manufacturing towards more personalised and advanced technologies have increased the necessity for services like small-volume compounding. PEAK-PCI's investment in new extrusion technologies provides a foundation for these industries to innovate without constraints, emphasising product functionality over manufacturability.